| Number of patients exposed to the drug during | Crude | Adjusted |  |  | ||||
---|---|---|---|---|---|---|---|---|---|
 | study period | case period but not control period | control period but not case period | OR* | 95%CI | OR+ | 95%CI | OR$ | 95%CI |
Oral | Â | Â | Â | Â | Â | Â | Â | Â | Â |
celecoxib | 210 | 81 | 55 | 1.47 | 1.05 - 2.07 | 1.42 | 0.99 - 2.04 | 1.36 | 0.95 - 1.96 |
non-selective NSAIDs | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   ketorolac | 76 | 43 | 11 | 3.91 | 2.02 - 7.58 |  |  | 2.02 | 1.00 - 4.09 |
   flurbiprofen | 129 | 54 | 29 | 1.86 | 1.19 - 2.92 |  |  | 1.71 | 1.06 - 2.74 |
   ibuprofen | 755 | 278 | 178 | 1.56 | 1.29 - 1.89 |  |  | 1.45 | 1.19 - 1.76 |
   sulindac | 242 | 93 | 61 | 1.53 | 1.10 - 2.11 |  |  | 1.44 | 1.02 - 2.03 |
   diclofenac | 1,731 | 624 | 421 | 1.48 | 1.31 - 1.68 |  |  | 1.29 | 1.13 - 1.47 |
   acemetacin | 349 | 136 | 93 | 1.46 | 1.12 - 1.90 |  |  | 1.28 | 0.96 - 1.70 |
   naproxen | 231 | 78 | 56 | 1.39 | 0.99 - 1.96 |  |  | 1.26 | 0.88 - 1.81 |
   piroxicam | 259 | 94 | 76 | 1.24 | 0.91 - 1.67 |  |  | 1.25 | 0.92 - 1.70 |
   indomethacin | 184 | 67 | 44 | 1.52 | 1.04 - 2.23 |  |  | 1.22 | 0.82 - 1.83 |
   ketoprofen | 70 | 28 | 22 | 1.27 | 0.73 - 2.23 |  |  | 1.17 | 0.64 - 2.11 |
   mefenamic acid | 1,070 | 370 | 294 | 1.23 | 1.08 - 1.47 |  |  | 1.16 | 0.98 - 1.36 |
   meloxicam | 327 | 106 | 96 | 1.10 | 0.84 - 1.46 |  |  | 0.97 | 0.73 - 1.30 |
   tiaprofenic acid | 92 | 31 | 28 | 1.11 | 0.66 - 1.85 |  |  | 0.91 | 0.52 - 1.57 |
ns-NSAIDs overall | 3,573 | 1,175 | 768 | 1.53 | 1.40 - 1.68 | 1.42 | 1.29 - 1.56 | Â | Â |
Parenteral | Â | Â | Â | Â | Â | Â | Â | Â | Â |
   ketorolac | 364 | 245 | 35 | 6.99 | 4.91 - 9.96 |  |  | 4.27 | 2.90 - 6.29 |
   ketoprofen | 125 | 69 | 20 | 3.45 | 2.10 - 5.68 |  |  | 2.34 | 1.31 - 4.19 |
   diclofenac | 70 | 34 | 12 | 2.83 | 1.47 - 5.46 |  |  | 1.88 | 0.95 - 3.75 |
Parenteral NSAIDs overall | 455 | 330 | 65 | 5.08 | 3.89 - 6.62 | 3.35 | 2.50 - 4.47 | Â | Â |